Chicago, IL - 2015 ASCO Annual Meeting - J. Silvio Gutkind, PhD presents Overcoming Resistance to Cetuximab with PIK3CA Mutations during PI3-Kinase: Genomics to Clinical Practice at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Sunday, May 31, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Zach Boyden-Holmes 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org